← Eichor
Study identifier: NCT07479602 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Intranasal Dexmedetomidine-esketamine Administration and Postoperative Pain in Pediatric Patients

Condition: Adenotonsillectomy · Children · Intranasal Administration  ·  Sponsor: Peking University First Hospital

PhasePhase 4
Planned participants160
Who can joinAll sexes, 3 Years to 7 Years
Healthy volunteersNo

About this study

Postoperative pain after adenoid and tonsil surgery is significant, with approximately 75% of pediatric patients experiencing severe postoperative pain. Currently, there is a lack of clinical strategies to safely and effectively manage postoperative pain in children undergoing adenoid and tonsil surgery. Dexmedetomidine and esketamine can achieve appropriate sedation levels and alleviate postoperative pain when used in children. Both drugs can be administered intranasally, and their pharmacological effects complement each other, reducing side effects. This study aims to investigate whether intranasal administration of dexmedetomidine-esketamine combination can improve postoperative analgesia in children undergoing adenoid and tonsil surgery.

This description comes directly from the study's public registry record.

Talk to the study team

Dong-Xin Wang, MD, PhD  ·  01083572784  ·  wangdongxin@hotmail.com

Ting Ding, MD  ·  athena_d@sina.com

Always discuss trial participation with your own doctor first.

Locations (1)

Peking University First HospitalBeijing, Beijing Municipality, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07479602